NDC 49702-227 – Tivicay
Dolutegravir Sodium 25 mg/1 · Tablet, Film Coated · Oral
Product NDC49702-227
Product details
- Brand name
- Tivicay
- Generic name
- Dolutegravir sodium
- Labeler
- ViiV Healthcare Company
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA204790
- Marketed since
- June 9, 2016
- Marketing end
- May 31, 2027
- Pharmacologic class
- Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor
Active ingredients
- Dolutegravir Sodium 25 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 49702-227-13 | 30 TABLET, FILM COATED in 1 BOTTLE (49702-227-13) | Jun 9, 2016 |
Recalls mentioning this NDC
- D-0544-2024 Jun 12, 2024 · Class III
Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR. - D-0896-2022 Jun 1, 2022 · Class III
Labeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was printed on the product labeling with an expiration date of January 2027, whereas the correct expiration… - D-1185-2014 Apr 9, 2014 · Class III
Cross Contamination with Other Products: Product contains Promacta (eltrombopag).